Case Control Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Jan 7, 2018; 24(1): 46-57
Published online Jan 7, 2018. doi: 10.3748/wjg.v24.i1.46
Figure 2
Figure 2 Immunohistochemical staining for leptin and leptin receptor in irritable bowel syndrome patients and healthy controls. A: Colonic mucosal leptin expression in IBS-D patients (× 400); B: Colonic mucosal leptin expression in healthy controls (× 400); C: Colonic mucosal leptin receptor expression in IBS-D patients (× 400); D: Colonic mucosal leptin receptor expression in healthy controls (× 400); E: Colonic mucosal leptin immunoreactivity significantly increased in IBS-D patients than in the healthy controls; F: Colonic mucosal leptin receptor immunoreactivity did not increase significantly in IBS-D patients than in healthy controls. Line in the scatter plots means the median. IBS-D: Iirritable bowel syndrome with diarrhea; IOD: Integral optical density.